SCHEMBL22736343

SCHEMBL22736343

N#CCc1coc(-n2cc(-c3ccnc(N)c3[N+](=O)[O-])cn2)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22735775 0.85 FEN1 (0.31) —
SCHEMBL22736126 0.78 EGLN1 (0.37) —
SCHEMBL29480720 0.78 EGLN1 (0.37) —
SCHEMBL31158290 0.76 RIPK2 (0.32) —
SCHEMBL22735962 0.74 GRM4 (0.35) —
SCHEMBL22736327 0.69 KCNJ1 (0.38) —
SCHEMBL29480741 0.69 KCNJ1 (0.38) —
SCHEMBL29480662 0.69 HTT (0.41) —
SCHEMBL22735911 0.69 GRM4 (0.35) —
SCHEMBL29480689 0.69 GRM4 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3976612-A1 NOVEL COMPOUNDS FOR INHIBITION OF JANUS KINASE 1 MANKIND PHARMA LTD (IN) 2022-04-06 — — EP disclosed
CN-114174294-A Novel compounds for inhibiting JANUS kinase 1 人类制药有限公司 2022-03-11 — — CN disclosed
WO-2020240586-A1 NOVEL COMPOUNDS FOR INHIBITION OF JANUS KINASE 1 MANKIND PHARMA LTD. (IN) 2020-12-03 — — WO disclosed
Send feedback